Skip to main navigation Skip to search Skip to main content

Cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort in a phase I study

  • M. J. Pishvaian
  • , G. J. Weiss
  • , G. S. Falchook
  • , N. Yee
  • , M. Gil-Martin
  • , S. Shahda
  • , V. Moreno
  • , I. Brana
  • , M. Crittenden
  • , S. Formenti
  • , R. Al-Rajabi
  • , K. P. Papadopoulos
  • , E. Stankevich
  • , M. Feng
  • , J. Li
  • , M. Mathias
  • , G. Kroog
  • , I. Lowy
  • , M. G. Fury

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)viii410
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
StatePublished - Oct 1 2018

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this